| Today’s Big NewsApr 9, 2025 |
|
Home to industry leaders like Amgen and AbbVie, Puerto Rico has over 70 years of pharmaceutical and biotech expertise. With a skilled workforce and world-class infrastructure, it remains a top destination for bioscience innovation. Find out how your company can thrive here. +(1)+(1).png)
|
|
| By James Waldron AstraZeneca has been busy in recent years picking up a shopping list of assets and companies that have pumped up its oncology pipeline. |
|
|
|
By Gabrielle Masson In the latest of a string of clawbacks, the Department of Health and Human Services is now sharing plans to cut contract spending by 35% across all divisions. |
By James Waldron With two attempts to merge with other companies having collapsed, Vincerx Pharma has been left with no choice but to start winding down. |
Sponsored by Allucent Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how sponsors can align with FDA expectations and implement more precise dose-finding strategies. Watch the full interview with Alex MacDonald now! |
|
BioIVT is launching a new system to access their vast repository of meticulously collected, detailed & verified biospecimen data spanning numerous therapeutic areas… Learn More >> 
|
|
By Gabrielle Masson On Monday, a federal judge permanently blocked the National Institutes of Health from implementing indirect cost caps on research grants. The NIH is now appealing. |
By Zoey Becker Peter Marks, M.D., Ph.D., the former director of the Center for Biologics Evaluation and Research, told the Associated Press that he blocked HHS secretary Robert F. Kennedy, Jr. from securing full access to the Vaccine Adverse Events Reports System in the fear that the secretary's team would erase the database. |
By Darren Incorvaia The Trump administration’s effort to slash federal funding to universities has found its latest targets, with the government reportedly freezing $1 billion in funds to Cornell University and $790 million to Northwestern University. |
By Darren Incorvaia The Trump administration has blocked access to multiple data repositories maintained by the National Institutes of Health for researchers in several countries, including a cancer statistics database used regularly by scientists in China. |
By Darren Incorvaia Researchers combined a vaccine and a probiotic supplement to tend the microbial garden inside the intestines of mice, protecting the rodents from harmful infections or treating them if they’ve already caught a nasty bug as scientists continue to seek a future alternative to antibiotics. |
By Darren Incorvaia Global CRO Worldwide Clinical Trials has enlisted AI tech firm NetraMark to discover patient subpopulations hidden inside complex data sets. |
By Conor Hale The revamped Kandu will move forward with $30 million in new financing, through a round co-led by Ally Bridge Group and Amed Ventures. |
By Kevin Dunleavy After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma Kewalramani, M.D., to $21.5 million, according to the company’s proxy filing. |
Fierce podcasts Don’t miss an episode |
| This week on "The Top Line," we dive into our special report ranking the top pharma R&D budgets for 2024. |
|
|---|
|
|
NashBio is transforming life sciences by making complex genomic and real-world data accessible for pharmaceutical R&D. Learn how their innovative Totem platform and groundbreaking Alliance for Genomic Discovery are accelerating research and improving outcomes. By NashBio |
eBook Typical vaccine development timelines have averaged 10 years, but the time from the SARS-CoV-2 genetic sequence’s release to the submission of the first vaccine clinical trial data for regulatory review was a mere 314 days. In IQVIA Laboratories’ Vaccine eBook we focus on how contract research organizations (CROs) can best leverage strategic partnerships with sponsors to prepare for the next pandemic. Sponsored by: IQVIA |
Whitepaper Avoid costly mistakes and ensure your clinical development program meets the highest standards by reading WCG’s whitepaper on Imaging Core Labs, Endpoint Adjudication Committees (EAC), and other safety reviews. Sponsored by: WCG |
Research We interviewed 15 biopharma leaders on the critical success factors for building a Best Practice customer-facing organization. This report shares what we learned. Presented by Blue Matter, strategic consultants in the life sciences |
| Accepting Nominations Now |
|
| Accepting Nominations Now |
|
|
| |
|
